$XNCR Cashflow Statement | Understand Stock

$XNCR

$29.21 +$0.03 (0.1%) After hours

$XNCR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss including noncontrolling interest
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Accretion of discount on marketable debt securities, net
Stock-based compensation
Gain on sale of marketable securities, net
Change in fair value of marketable equity securities
Addition of right-of-use asset
Cash and cash equivalents
Restricted cash
Asset impairment charges
Non-cash royalty revenue related to the sale of future royalties
Non-cash interest expense on liabilities related to the sale of future royalties
Equity received in connection with license agreement
Equity received in connection with sale of financial assets
Cash redemption of equity received in connection with license agreement
Equity securities impairment
Change in fair value of equity securities
Impairment on equity securities
Abandonment of capitalized intangibles
Loss on disposal of assets
Changes in operating assets and liabilities:
Accounts receivable
Interest receivable from marketable debt securities
Prepaid expenses and other assets
Contract asset and deposits
Accounts payable
Accrued expenses
Income taxes
Operating lease, net
Deferred revenue
Deferred income
Other assets and liabilities, net

Net cash used in operating activities
Cash flows from investing activities
Proceeds from maturities of marketable debt securities available-for-sale
Proceeds from sale of marketable debt securities available-for-sale
Purchase of marketable debt securities
Purchase of property and equipment
Purchase of convertible note
Conversion of convertible note
Exercise of stock options
Purchase of patents
Proceeds from sales of marketable equity securities
Proceeds from sales and maturities of marketable debt securities
Proceeds from sale of property and equipment
Net cash provided by (used in) investing activities

Cash flows from financing activities
Proceeds from the exercises of stock options
Proceeds from issuance of common stock under the Employee Stock Purchase Plan
Proceeds from issuance of common stock and pre-funded warrants
Common stock and pre-funded warrants issuance costs
Proceeds from the sale of future royalties
Proceeds from noncontrolling interest
Cash paid to acquire noncontrolling interest
Net cash provided by financing activities
Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash, beginning of period
Cash, cash equivalents, and restricted cash, end of period
Supplemental disclosure of cash flow information
Interest paid
Income taxes paid
Unrealized loss on marketable securities

Comments